Article
p53-deficient cells display increased sensitivity to anthracyclines after loss of the catalytic subunit of the DNA-dependent protein kinase.
International journal of oncology - 1 Nov 2003
Fedier André, Moawad Ahmed, Haller Urs, Fink Daniel
Abstract excerpt
DNA-dependent protein kinase (DNA-PK) is involved in non-homologous end joining which repairs DNA double-strand breaks introduced by irradiation and radiomimetic agents. DNA-PK interacts with p53 but may also have p53-independent functions. The present study investigated whether disruption of the gene for the catalytic subunit DNA-PKcs affects chemosensitivity in p53-deficient cells. Drug sensitivity of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
